Oruka Therapeutics, Inc.

ORKA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$91,253$65,396$83,572$61,575
Short-Term Investments$257,902$263,010$265,522$314,073
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$6,008$3,606$2,989$1,221
Total Curr. Assets$355,163$332,012$352,083$376,869
Property Plant & Equip (Net)$2,222$2,250$973$1,038
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$151,763$23,053$23,953$18,069
Tax Assets$0$0$0$0
Other NC Assets$103$103$103$43
Total NC Assets$154,088$25,406$25,029$19,150
Other Assets$0$0$0$0
Total Assets$509,251$357,418$377,112$396,019
Liabilities
Payables$2,208$4,664$3,545$3,462
Short-Term Debt$419$660$283$213
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$15,494$5,102$7,077$7,327
Total Curr. Liab.$20,967$12,110$11,723$13,043
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$1,493$1,666$664$755
Other Liabilities$0$0$0$0
Cap. Leases$1,912$2,326$947$968
Total Liabilities$22,460$13,776$12,387$13,798
Equity
Pref Stock$2,931$2,931$2,931$2,931
Common Stock$48$37$37$37
Retained Earnings-$159,574-$129,297-$104,723-$83,724
AOCI$185-$27-$6-$41
Other Equity$0$0$0$0
Total Equity$486,791$343,642$364,725$382,221
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$509,251$357,418$377,112$396,019
Net Debt-$90,834-$64,736-$83,289-$61,362